- Home
- ALDX vs SNFCA Comparison
ALDX vs SNFCA Comparison
Compare ALDX & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALDX | SNFCA |
|---|---|---|
| Founded | 2004 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.1M | 229.2M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALDX | SNFCA |
|---|---|---|
| Price | $1.19 | $8.78 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 632.7K | 22.5K |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.43 | 13.51 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $344,587,538.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.67 |
| Revenue Growth | N/A | ★ 3.01 |
| 52 Week Low | $1.07 | $7.70 |
| 52 Week High | $5.93 | $10.23 |
Technical Indicators
Market Signals| Indicator | ALDX | SNFCA |
|---|---|---|
| Relative Strength Index (RSI) | 29.76 | 46.77 |
| Support Level | $1.07 | $8.53 |
| Resistance Level | $1.58 | $9.80 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 5.19 | 60.61 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About SNFCA Security National Financial Corporation
Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.